Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-06-10 | Mr. Gelbman, 68, is a former member of the Executive Committee of Johnson & Johnson... Mr. Gelbman served as Interim Chief Executive Officer of Haemonetics from September 2015 to May 2016. He has been a member of the Haemonetics Board of Directors since 2000 and, except during his appointment as Interim CEO, serves as Chair of the Governance & Compliance Committee and a member of the Audit Committee. |
Data sourced from SEC filings. Last updated: 2025-08-30